Abstract
Stroke is the most common life-threatening neurological disease and is the fourth leading cause of death among adult Canadians. Aspirin is the most frequently prescribed antithrombotic drug to prevent stroke but may not be a suitable choice in older patients who have already had stroke symptoms despite its use, or cannot tolerate its side effects. For these patients, clopidogrel or the combination of low-dose aspirin with extended release (ER) dipyridamole should be considered for prevention of stroke, This review will compare the relative benefits of aspirin, clopidogrel, and low-dose aspirin/ER-dipyridamole in geriatric patients at risk for stroke.
Original language | English |
---|---|
Pages (from-to) | 15-19 |
Number of pages | 5 |
Journal | Geriatrics and Aging |
Volume | 7 |
Issue number | 8 |
State | Published - Sep 2004 |
Keywords
- Aspirin
- Clopidogrel
- Dipyridamole
- Myocardial infarction
- Stroke
ASJC Scopus subject areas
- Aging
- Gerontology
- Geriatrics and Gerontology